Sign in →

Test Code 170170 NGS HEMATOLYMPHOID REPORT

Test ID

1790

Container Type

Laboratory Container Default Temperature Minimum Volume
NGS LAB STERILE CONTAINER Yes

Performing Section

NGS LAB

Components

Component Name Component ID LOINC Code
CASE SUMMARY 43600030
HUMAN REFERENCE SEQUENCE ASSEMBLY 43650010 62374-4 (Human reference sequence assembly release number:ID:Pt:Bld/Tiss:Nom:Molgen)
VARIANT CATEGORY 43650015 83005-9 (Variant category:Type:Pt:^Patient:Nom:)
GENE STUDIED 43650017 48018-6 (Gene identifier:ID:Pt:Bld/Tiss:Nom:Molgen)
TRANSCRIPT REFERENCE SEQUENCE ID 43650018 51958-7 (Transcript reference sequence identifier:ID:Pt:Bld/Tiss:Nom:Molgen)
DNA CHANGE 43650019 48004-6 (DNA change:Find:Pt:Bld/Tiss:Nom:Molgen)
AMINO ACID CHANGE 43650020 48005-3 (Amino acid change:Find:Pt:Bld/Tiss:Nom:Molgen)
DNA CHANGE TYPE 43650021 48019-4 (DNA change type:Type:Pt:Bld/Tiss:Nom:Molgen)
AMINO ACID CHANGE TYPE 43650022 48006-1 (Amino acid change type:Type:Pt:Bld/Tiss:Nom:Molgen)
GENOMIC REFERENCE ALLELE 43650025 69547-8 (Reference nucleotide:Prid:Pt:Bld/Tiss:Nom:Molgen)
GENOMIC ALLELE START/END 43650026 81254-5 (Genomic allele start-end:ID:Pt:^Patient:Nom:)
GENOMIC ALT ALLELE 43650027 69551-0 (Variable nucleotide:Prid:Pt:Bld/Tiss:Nom:Molgen)
CYTOGENETIC LOCATION 43650028 48001-2 (Chromosome region:ID:Pt:Bld/Tiss:Nom:Molgen)
GENOMIC SOURCE CLASS 43650029 48002-0 (Genomic source class:Type:Pt:Bld/Tiss:Nom:Molgen)
VARIANT ANALYSIS METHOD TYPE 43650030 81304-8 (Structural variant analysis method:Type:Pt:^Patient:Nom:)
GENETIC SEQUENCE VARIATION CLINICAL SIGNIFICANCE 43650031 53037-8 (Genetic disease sequence variation interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen)
VARIANT ALLELIC FREQUENCY 43650034 81258-6 (Allelic frequency:NFr:Pt:^Patient:Qn:)
ALLELIC READ DEPTH 43650035 82121-5 (Allelic read depth:Num:Pt:^Patient:Qn:)
ALLELIC PHASE 43650036 82120-7 (Allelic phase:Type:Pt:^Patient:Nom:)
BASIS FOR ALLELIC PHASE 43650037 82309-6 (Basis for allelic phase:Type:Pt:^Patient:Nom:)
STRUCTURAL COPY NUMBER 43650038 82155-3 (Genomic structural variant copy number:Num:Pt:^Patient:Qn:)
STRUCTURAL REPORTED ARRCGH RATIO 43650039 81299-0 (Structural variant reported arrCGH:Ratio:Pt:^Patient:Qn:)
STRUCTURAL VARIANT LENGTH 43650040 81300-6 (Structural variant:Len:Pt:^Patient:Qn:)
STRUCTURAL OUTER START/END 43650041 81301-4 (Structural variant outer start-end:NumRange:Pt:^Patient:Qn:)
STRUCTURAL INNER START/END 43650042 81302-2 (Structural variant inner start-end:NumRange:Pt:^Patient:Qn:)
VARIANT DISPLAY NAME 43650043 47998-0 (DNA sequence variation display name:Txt:Pt:Bld/Tiss:Nar:Molgen)
CHROMOSOME 43650044 48000-4 (Chromosome:ID:Pt:Bld/Tiss:Nom:Molgen)
DNA REGION 43650045 47999-8 (DNA region name:ID:Pt:Bld/Tiss:Nom:Molgen)
FUSED GENES 43650051
GENETIC VARIANT ASSESSMENT 43650052 69548-6 (Genetic variant assessment:Find:Pt:Bld/Tiss:Nom:Molgen)
INTERPRETATION 43650053
REASON FOR STUDY 43600001 53577-3 (Reason for study additional note:Txt:Pt:Bld/Tiss:Nar:Molgen)
DESCRIPTION OF RANGES OF DNA SEQUENCES EXAMINED 43600003 81293-3 (Range(s) of DNA sequences examined:Txt:Pt:^Patient:Nar:)
OVERALL INTERPRETATION 43600004 51968-6 (Genetic disease analysis overall interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen)
MSI 43600005 81695-9 (Microsatellite instability:Imp:Pt:Cancer specimen:Ord:)
ANSWER REPORT 43600026
TUMOR MUTATIONAL BURDEN INTERPRETATION 43600027
TMB 43600007 48025-1 (Gene mutations tested for:Num:Pt:Bld/Tiss:Qn:Molgen)